Taizo Hanai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Taizo Hanai has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Takeshi Kobayashi
Department of Biotechnology, School of Engineering, Nagoya University
19 shared publications- Hiroyuki Honda
Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan
14 shared publications Hiroyuki Honda
Department of Biotechnology, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8603, Japan
8 shared publicationsYasutaka Hirokawa
Laboratory for Bioinformatics, Graduate School of Systems Biosciences, Kyushu University, W5-729, 744, Motooka, Nishi-ku, Fukuoka, 819-0395, Japan
8 shared publications- Yuki Soma
Division of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
8 shared publications Hideki Noguchi
Deparlment of Biotechnology, Graduate School of Engineering, Nagoya University
5 shared publications
Latest Publications
- Open Access
A hybrid in silico /in-cell controller for microbial bioprocesses with process-model mismatch
The optimization of bioprocess inputs using mathematical models is widely practiced. However, the mismatch between model prediction and the actual process [called process-model mismatch (PMM)] is problematic; when a large PMM exists, the process inputs optimized using the mathematical model in advance are no longer optimal for the actual process. In this study, we propose a hybrid control system that combines model-based optimization ( in silico feedforward controller) and feedback controllers using synthetic genetic circuits integrated into cells (in-cell feedback controller) – which we named the hybrid in silico /in-cell controller (HISICC) – as a solution to this PMM issue. As a proof of concept for HISICC, we constructed a mathematical model of an engineered Escherichia coli strain for the isopropanol production process that was previously developed. This strain contains an in-cell feedback controller, and its combination with an in silico controller can be regarded as an example of HISICC. We demonstrated the robustness of HISICC against PMM by comparing the strain with another strain with no in-cell feedback controller in simulations assuming PMM of various magnitudes.
Open AccessA hybrid in silico /in-cell controller for microbial bioprocesses with process-model mismatch
The optimization of bioprocess inputs using mathematical models is widely practiced. However, the mismatch between model prediction and the actual process [called process-model mismatch (PMM)] is problematic; when a large PMM exists, the process inputs optimized using the mathematical model in advance are no longer optimal for the actual process. In this study, we propose a hybrid control system that combines model-based optimization ( in silico feedforward controller) and feedback controllers using synthetic genetic circuits integrated into cells (in-cell feedback controller) – which we named the hybrid in silico /in-cell controller (HISICC) – as a solution to this PMM issue. As a proof of concept for HISICC, we constructed a mathematical model of an engineered Escherichia coli strain for the isopropanol production process that was previously developed. This strain contains an in-cell feedback controller, and its combination with an in silico controller can be regarded as an example of HISICC. We demonstrated the robustness of HISICC against PMM by comparing the strain with another strain with no in-cell feedback controller in simulations assuming PMM of various magnitudes.
- 1 January 2022
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 133 (1) , 56-63
Dynamic metabolic engineering of Escherichia coli improves fermentation for the production of pyruvate and its derivatives
- 1 January 2022
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 133 (1) , 56-63
Dynamic metabolic engineering of Escherichia coli improves fermentation for the production of pyruvate and its derivatives
- 1 January 2022
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 133 (1) , 46-55
Quantitative metabolomics for dynamic metabolic engineering using stable isotope labeled internal standards mixture (SILIS)
- 1 January 2022
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 133 (1) , 46-55
Quantitative metabolomics for dynamic metabolic engineering using stable isotope labeled internal standards mixture (SILIS)
- 1 January 2020
- Published by Elsevier in Metabolic Engineering
- Vol. 57, 23-30
Enhancement of acetyl-CoA flux for photosynthetic chemical production by pyruvate dehydrogenase complex overexpression in Synechococcus elongatus PCC 7942
- 1 January 2020
- Published by Elsevier in Metabolic Engineering
- Vol. 57, 23-30
Enhancement of acetyl-CoA flux for photosynthetic chemical production by pyruvate dehydrogenase complex overexpression in Synechococcus elongatus PCC 7942
- 1 September 2019
- Published by Elsevier in Metabolic Engineering
- Vol. 55, 268-275
Synthetic microbial consortium with specific roles designated by genetic circuits for cooperative chemical production
- 1 September 2019
- Published by Elsevier in Metabolic Engineering
- Vol. 55, 268-275
Synthetic microbial consortium with specific roles designated by genetic circuits for cooperative chemical production
- 1 February 2019
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 127 (2) , 256-264
Modification of carbon metabolism in Synechococcus elongatus PCC 7942 by cyanophage-derived sigma factors for bioproduction improvement
- 1 February 2019
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 127 (2) , 256-264
Modification of carbon metabolism in Synechococcus elongatus PCC 7942 by cyanophage-derived sigma factors for bioproduction improvement
- 1 May 2018
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 125 (5) , 572-577
Mutations responsible for alcohol tolerance in the mutant of Synechococcus elongatus PCC 7942 (SY1043) obtained by single-cell screening system
- 1 May 2018
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 125 (5) , 572-577
Mutations responsible for alcohol tolerance in the mutant of Synechococcus elongatus PCC 7942 (SY1043) obtained by single-cell screening system
- Open Access
- 25 November 2017
- Published by Springer Nature in Microbial Cell Factories
- Vol. 16 (1) , 1-12
Metabolic engineering of Synechococcus elongatus PCC 7942 for improvement of 1,3-propanediol and glycerol production based on in silico simulation of metabolic flux distribution
Production directly from carbon dioxide by engineered cyanobacteria is one of the promising technologies for sustainable future. Previously, we have successfully achieved 1,3-propanediol (1,3-PDO) production using Synechococcus elongatus PCC 7942 with a synthetic metabolic pathway. The strain into which the synthetic metabolic pathway was introduced produced 3.48 mM (0.265 g/L) 1,3-PDO and 14.3 mM (1.32 g/L) glycerol during 20 days of incubation. In this study, the productivities of 1,3-PDO were improved by gene disruption selected by screening with in silico simulation. First, a stoichiometric metabolic model was applied to prediction of cellular metabolic flux distribution in a 1,3-PDO-producing strain of S. elongatus PCC 7942. A genome-scale model of S. elongatus PCC 7942 constructed by Knoop was modified by the addition of a synthetic metabolic pathway for 1,3-PDO production. Next, the metabolic flux distribution predicted by metabolic flux balance analysis (FBA) was used for in silico simulation of gene disruption. As a result of gene disruption simulation, NADPH dehydrogenase 1 (NDH-1) complexes were found by screening to be the most promising candidates for disruption to improve 1,3-PDO production. The effect of disruption of the gene encoding a subunit of the NDH-1 complex was evaluated in the 1,3-PDO-producing strain. During 20 days of incubation, the ndhF1-null 1,3-PDO-producing strain showed the highest titers: 4.44 mM (0.338 g/L) 1,3-PDO and 30.3 mM (2.79 g/L) glycerol. In this study, we successfully improved 1,3-PDO productivity on the basis of in silico simulation of gene disruption.
- 25 November 2017
- Published by Springer Nature in Microbial Cell Factories
- Vol. 16 (1) , 1-12
Open AccessMetabolic engineering of Synechococcus elongatus PCC 7942 for improvement of 1,3-propanediol and glycerol production based on in silico simulation of metabolic flux distribution
Production directly from carbon dioxide by engineered cyanobacteria is one of the promising technologies for sustainable future. Previously, we have successfully achieved 1,3-propanediol (1,3-PDO) production using Synechococcus elongatus PCC 7942 with a synthetic metabolic pathway. The strain into which the synthetic metabolic pathway was introduced produced 3.48 mM (0.265 g/L) 1,3-PDO and 14.3 mM (1.32 g/L) glycerol during 20 days of incubation. In this study, the productivities of 1,3-PDO were improved by gene disruption selected by screening with in silico simulation. First, a stoichiometric metabolic model was applied to prediction of cellular metabolic flux distribution in a 1,3-PDO-producing strain of S. elongatus PCC 7942. A genome-scale model of S. elongatus PCC 7942 constructed by Knoop was modified by the addition of a synthetic metabolic pathway for 1,3-PDO production. Next, the metabolic flux distribution predicted by metabolic flux balance analysis (FBA) was used for in silico simulation of gene disruption. As a result of gene disruption simulation, NADPH dehydrogenase 1 (NDH-1) complexes were found by screening to be the most promising candidates for disruption to improve 1,3-PDO production. The effect of disruption of the gene encoding a subunit of the NDH-1 complex was evaluated in the 1,3-PDO-producing strain. During 20 days of incubation, the ndhF1-null 1,3-PDO-producing strain showed the highest titers: 4.44 mM (0.338 g/L) 1,3-PDO and 30.3 mM (2.79 g/L) glycerol. In this study, we successfully improved 1,3-PDO productivity on the basis of in silico simulation of gene disruption.